Research on the significance of the microbiome in Crohn's disease therapy (IMAGE)
Caption
In a joint study, Prof. Dirk Haller and Dr. Tobias Schwerd demonstrated how the gut microbiome changes during nutritional therapy. Prof. Dr. Dirk Haller (left) is a professor of nutrition and immunology at TUM and director of the Central Institute for Nutrition and Food Research. PD Dr. Tobias Schwerd is the head of pediatric gastroenterology and hepatology at Dr. von Hauner Children's Hospital. Building on these findings, a joint clinical trial is now launching at the Dr. von Hauner Children's Hospital at LMU University Hospital Munich.
Credit
Astrid Eckert / TUM
Usage Restrictions
Free for use in reporting on TUM, with the copyright noted
License
Original content